Stereotactic Ablative Radiotherapy for Kidney Tumors

Phase-Based Progress Estimates
Royal Victoria Regional Health Centre, Barrie, CanadaKidney TumorsStereotactic Ablative Radiotherapy - Radiation
All Sexes
What conditions do you have?

Study Summary

This trial will investigate whether the use of stereotactic ablative radiosurgery (SABR) is a non-invasive, effective alternative treatment for renal tumors in patients who are not suitable candidates for surgery.

Eligible Conditions
  • Kidney Tumors

Treatment Effectiveness

Study Objectives

1 Primary · 4 Secondary · Reporting Duration: 2 years

2 years
2-year Local recurrence rate
Chronic Kidney Disease Stage Progression
Incidence of acute and late toxicities
Patient Reported Outcomes
To evaluate the radiation induced renal impairments in patients receiving SABR.

Trial Safety

Trial Design

1 Treatment Group

Stereotactic Ablative Radiotherapy
1 of 1

Experimental Treatment

30 Total Participants · 1 Treatment Group

Primary Treatment: Stereotactic Ablative Radiotherapy · No Placebo Group · N/A

Stereotactic Ablative Radiotherapy
Experimental Group · 1 Intervention: Stereotactic Ablative Radiotherapy · Intervention Types: Radiation

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 2 years

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor
1,386 Previous Clinical Trials
471,939 Total Patients Enrolled
Joelle Helou, MDPrincipal InvestigatorUniversity Health Network--Princess Margaret Cancer Centre
Rachel Glicksman, MDPrincipal InvestigatorThe Princess Margaret Cancer Foundation

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

What is the scope of patients receiving treatment as part of this experiment?

"Affirmative. confirms that this clinical trial, which was first made public on the 1st of November 2018, is still searching for participants. There are 30 spots available to be filled at two different sites." - Anonymous Online Contributor

Unverified Answer

Has enrollment opened for this experiment yet?

"The clinical trial, which was initially launched on November 1st 2018, is still recruiting patients according to the information found on The last update occurred October 17th 2022." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.